Ardelyx Announces $50 Million Stock Offering
Ardelyx
Flag link:
House passes “right-to-try” — allowing the terminally ill to ask companies for experimental drugs outside of FDA’s purview
House passes “right-to-try” — allowing the terminally ill to ask companies for experimental drugs outside of FDA’s purview
Biopharma Dive
right-to-try laws
FDA
Senate
congress
regulatory
Flag link:
Takeda makes $280M divestiture amid Shire buy
Takeda makes $280M divestiture amid Shire buy
Biopharma Dive
Takeda
Shire
M&A
Guangdong Techpool Bio-Pharma
Flag link:
FDA plans to speed path to approval for some gene therapies, starting with hemophilia
FDA plans to speed path to approval for some gene therapies, starting with hemophilia
Stat
FDA
drug approvals
gene therapies
Scott Gottlieb
hemophilia
Flag link:
Critical Condition: Inside Pfizer’s Drug Supply Problem
Critical Condition: Inside Pfizer’s Drug Supply Problem
Fortune
Pfizer
drug shortages
Flag link:
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
CP Wire
Cognition Therapeutics
Elayta
NIH
grants
Alzheimer's disease
Flag link:
Cohen scandal disrupts ex-Novartis CEO's move to hedge fund board: WSJ
Cohen scandal disrupts ex-Novartis CEO's move to hedge fund board: WSJ
Fierce Pharma
Novartis
Joe Jimenez
Donald Trump
Michael Cohen
Flag link:
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Amgen
FDA
Aimovig
migraines
Prolia
Flag link:
J&J, Pfizer, Merck again lead pharma in Fortune 500
J&J, Pfizer, Merck again lead pharma in Fortune 500
Biopharma Dive
Fortune 500
Big Pharma
JNJ
Merck
Pfizer
Flag link:
Breast Cancer Cells Use In-House Recycling To Survive After Spreading
Breast Cancer Cells Use In-House Recycling To Survive After Spreading
Forbes
breast cancer
metastatic breast cancer
autophagy
Novartis
Pfizer
Flag link:
May 22 2018 - Ex-Valeant, Philidor execs found guilty of kickback scheme
Flag link:
Ex-Valeant, Philidor executives found guilty of kickback scheme
Ex-Valeant, Philidor executives found guilty of kickback scheme
Business Insider
Valeant Pharmaceuticals
Philidor Rx
kickbacks
fraud
Gary Tanner
Flag link:
FDA approves first TPO agonist for chronic liver disease
FDA approves first TPO agonist for chronic liver disease
Biopharma Dive
FDA
Dova Pharmaceuticals
Doptelet
chronic liver disease
thrombocytopenia
Flag link:
Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine
Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine
CP Wire
Pfizer
vaccines
RSV
clinical trials
RSV Vaccine
Flag link:
Senators to Big Pharma: Better step up with drug prices in DTC ads, or we'll make you
Senators to Big Pharma: Better step up with drug prices in DTC ads, or we'll make you
Fierce Pharma
drug pricing
DTC advertising
Senate
Flag link:
Gates Foundation and U.K. pledge $50M to superbug treatment drive
Gates Foundation and U.K. pledge $50M to superbug treatment drive
Fierce Biotech
superbugs
antibiotic resistance
Bill Gates
Gates Foundation
UK
CARB-X
Flag link:
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis
CP Wire
FibroGen
pamrevlumab
IPF
idiopathic pulmonary fibrosis
Flag link:
Tribe taking steps to ‘ramp up’ drug patent business
Tribe taking steps to ‘ramp up’ drug patent business
Drug Delivery Business News
Native Americans
Allergan
generics
patents
Flag link:
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
RAPS.org
Alzheimer's disease
FDA
Roche
AstraZeneca
Bioclinica
Eli Lilly
Denali Therapeutics
Flag link:
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
Cognition Therapeutics
Alzheimer's disease
Flag link:

Pages